Abstract: The present disclosure relates to a micron silver particle-reinforced 316L stainless steel matrix composite, including a 316L stainless steel matrix and silver particles uniformly distributed in the 316L stainless steel matrix. The silver particles have a weight 1% to 5% of the total weight of the composite; and the composite has a density of 7.9 g/cm3 to 8.2 g/cm3 and a relative density of more than 98%. The composite is prepared by the following method: mixing raw materials of a spherical silver powder and a spherical 316L stainless steel powder; subjecting a resulting mixture to mechanical ball milling to obtain a mixed powder; sieving the mixed powder and adding a resulting powder to a powder cylinder of an SLM forming machine; and charging an inert protective gas for printing to obtain the composite.

Abstract: A content sharing method includes: receiving a first input for a first electronic device; and displaying a first interface on a screen of the first electronic device in response to the first input, the first interface including at least one of following: a first identifier or N second identifiers, where the first electronic device is one of N electronic devices constituting a target sharing group, the first identifier is an entry to a first content, and the first content is the content shared in the target sharing group by at least two of the N electronic devices; the second identifier is an entry to a second content, and the second content is the content shared in the target sharing group by one of the N electronic devices; and N is a positive integer greater than or equal to 2.

Abstract: The present invention is generally directed to novel functionalized biomolecules and methods for generating such biomolecules. Biomolecules may generally include nucleic acids, peptides, multicomponent molecular complexes and/or any other molecular products that may be produced by living organisms. The present invention is further directed to cells and/or organisms manipulated to produce such functionalized biomolecules. The cells contemplated by the present invention include both prokaryotic as well as eukaryotic cells. The functionalized biomolecules are produced via materials introduced into the cell using standard molecular biology techniques or are incorporated within the genomic nucleic acid of a cell by standard recombination techniques. Further contemplated is the use of such cells for sequestration of target molecules within the cells.

Abstract: The present invention is generally directed to novel functionalized biomolecules and methods for generating such biomolecules. Biomolecules may generally include nucleic acids, peptides, multicomponent molecular complexes and/or any other molecular products that may be produced by living organisms. The present invention is further directed to cells and/or organisms manipulated to produce such functionalized biomolecules. The cells contemplated by the present invention include both prokaryotic as well as eukaryotic cells. The functionalized biomolecules are produced via materials introduced into the cell using standard molecular biology techniques or are incorporated within the genomic nucleic acid of a cell by standard recombination techniques. Further contemplated is the use of such cells for sequestration of target molecules within the cells.

Abstract: The present invention relates to methods of generating amounts of selective nucleic acids. The present invention further relates to selective nucleic acids incorporated within non-coding nucleic acids, capable of binding to or altering a target molecule. Selective nucleic acids may generally refer to, but are not limited to, deoxyribonucleic acids (DNAs), ribonucleic acids (RNAs), artificially modified nucleic acids, combinations or modifications thereof. Selective nucleic acids may also generally refer to, but are not limited to, nucleic acid aptamers, aptazymes, ribozymes, deoxyribozymes, nucleic acid probes, small interfering RNAs (siRNAs), micro RNAs (miRNAs), short hairpin RNAs (shRNAs), antisense nucleic acids, diagnostic probes or probe libraries, aptamer inhibitors, precursors of any of the above and/or combinations or modifications thereof. In one aspect, a method for generating amounts of selective nucleic acids includes incorporating a selective nucleic acid sequence into a carrier nucleic acid.

Abstract: A neonate dummy make it possible to sense or measure a movement of the head of a neonate, the values of impacts applied to the thoracic part and the abdominal part (including the lumbar part) of the neonate, and the value or magnitude of the effect on the cervical vertebrae, as well as to clarify the mechanism of cervical disorder resulting from an impact in a car crash or the like. This neonate dummy includes a head part, a body part (including a lumbar part), arm parts and leg parts. A bar-shaped backbone member corresponding to the backbone of a neonate is provided in the body part (including a lumbar part), and a neck part is formed on an upper region of the backbone member. A triaxial acceleration sensor is provided on the centroidal position of the head part.

Abstract: A neonate dummy enabling grasp of a movement of the head of a neonate, the values of impacts applied to the thoracic part and the abdominal part (including the lumbar part) and the value of affection on the cervical vertebrae as well as clarification of the mechanism of cervical disorder resulting from an impact in a car crash or the like is provided. This neonate dummy comprises a head part, a body part (including a lumbar part), arm parts and leg parts. A bar-shaped backbone member corresponding to the backbone of a neonate is provided in the body part (including a lumbar part), and a neck part is formed on an upper region of the backbone member. A triaxial acceleration sensor is provided on the centroidal position of the head part.